Marketplace Tech
Bytes: Week in Review — Investments flow into health tech, FDA approves modifying AI medical devices, and California’s AI insurance claim law
Dec 13, 2024
Christina Farr, managing director with Manatt Health, dives into the transformative role of AI in healthcare. She discusses a surge in investments for AI-driven health tech startups, showcasing a rebound after 2023's slump. The FDA's new guidelines enabling software updates post-approval are explored as a pivotal step in tech innovation. Farr also highlights California’s groundbreaking law mandating human oversight for AI in healthcare, raising critical conversations about transparency and the ethical implications of automated decision-making.
11:55
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Health tech startups, particularly those leveraging AI, are seeing a resurgence in investments despite a general funding slowdown post-pandemic.
- The FDA's new guidance allows AI medical device makers to update algorithms post-approval, enhancing functionality while addressing regulatory concerns.
Deep dives
The Rise of AI in Health Tech Startups
Health tech startups have experienced a resurgence in investment, particularly those integrating artificial intelligence into their solutions. The pandemic initially inflated funding levels as virtual care gained popularity, but this trend has since plateaued with more patients returning to in-person visits. Despite a more subdued atmosphere for funding compared to pandemic highs, AI remains the focal point for investment, with many investors explicitly seeking AI integration in proposals. However, while AI technology shows promise, the majority of revenue in healthcare continues to flow from traditional services involving patient care interactions.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
